Home49J • FRA
add
Caris Life Sciences Inc
Previous close
€23.60
Day range
€23.80 - €23.80
Year range
€20.20 - €34.20
Market cap
7.97B USD
Avg Volume
35.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 216.83M | 113.38% |
Operating expense | 114.86M | 9.13% |
Net income | 24.32M | 135.92% |
Net profit margin | 11.22 | 116.83% |
Earnings per share | 0.08 | — |
EBITDA | 37.51M | 174.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 755.49M | — |
Total assets | 984.57M | — |
Total liabilities | 506.21M | — |
Total equity | 478.36M | — |
Shares outstanding | 282.15M | — |
Price to book | 13.88 | — |
Return on assets | 8.41% | — |
Return on capital | 9.18% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 24.32M | 135.92% |
Cash from operations | 62.42M | 189.91% |
Cash from investing | -7.10M | -288.13% |
Cash from financing | -21.10M | -24,349.43% |
Net change in cash | 34.30M | 148.18% |
Free cash flow | 35.86M | — |
About
Founded
2008
Headquarters
Website
Employees
1,769
